English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART

MPS-Authors
/persons/resource/persons45492

Sing,  Tobias
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

/persons/resource/persons44105

Beerenwinkel,  Niko
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

/persons/resource/persons44907

Lengauer,  Thomas
Computational Biology and Applied Algorithmics, MPI for Informatics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Lehmann, C., Däumer, M., Bousaad, I., Sing, T., Beerenwinkel, N., Lengauer, T., et al. (2006). Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART. Journal of Clinical Virology, 37, 300-304.


Cite as: https://hdl.handle.net/11858/00-001M-0000-000F-23FF-7
Abstract
Background Disease progression in HIV infection has been associated with switch of viral coreceptor usage from CCR5 to CXCR4. Objectives To investigate the relationship between HIV-coreceptor tropism and clinical and virological outcome in 40 heavily pretreated patients over time. Methods Coreceptor phenotype was predicted after sequencing the V3 loop of the HIV glycoprotein 120. Results Coreceptor use was stable during observation time in 87% of patients, and CCR5 tropism was predominant. Viral mutations in the pol gene and clinical parameters were not predictive for coreceptor switching. Conclusions Even in patients with repeated HAART failure, CCR5 antagonists might be a valuable treatment option.